Ladenburg Thalmann Financial Services’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$31K	Buy	1,321 +645	+95%	+$14K	﹤0.01%	3855
2019 Q3	$14K	Hold	676	–	–	﹤0.01%	4225
2019 Q2	$14K	Hold	676	–	–	﹤0.01%	4260
2019 Q1	$14K	Hold	676	–	–	﹤0.01%	4204
2018 Q4	$13K	Hold	676	–	–	﹤0.01%	4127
2018 Q3	$16K	Buy	676 +282	+72%	+$6.54K	﹤0.01%	4035
2018 Q2	$8K	Hold	394	–	–	﹤0.01%	4366
2018 Q1	$8K	Sell	394 -84	-18%	-$1.84K	﹤0.01%	4366
2017 Q4	$10K	Hold	478	–	–	﹤0.01%	4178
2017 Q3	$10K	Hold	478	–	–	﹤0.01%	4079
2017 Q2	$10K	Buy	+478	New	+$9.62K	﹤0.01%	4002

Other funds holding FTXH

JAWM

J. Arnold Wealth Management Youngstown, Ohio $294M AUM 33.6% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

SMFS

Squar Milner Financial Services Irvine, California $176M AUM 10.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ladenburg Thalmann Financial Services's FTXH Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its First Trust Nasdaq Pharmaceuticals ETF (FTXH) stake by 95% in Q4 2019, buying an estimated $14K and bringing the position to 1,321 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #3855.

Ladenburg Thalmann Financial Services first reported a position in FTXH in Q2 2017 and has held it in 11 quarters since. 11 funds tracked by Wall St. Rank hold FTXH as of Q4 2019.

Ladenburg Thalmann Financial Services held 1,321 shares of First Trust Nasdaq Pharmaceuticals ETF worth $31K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 645 First Trust Nasdaq Pharmaceuticals ETF shares in Q4 2019, an estimated $14K.
First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3855 holding.
Ladenburg Thalmann Financial Services first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2017 and has held it in 11 quarters since.
11 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.